This is a non-core endpoint: only basic statistics are computed.
Fetus and newborn affected by complications of placenta, cord and membranes
P16_FET_NEWB_COMPLICATIO_PLACEN_CORD_MEMBRANES
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
51
Check minimum number of events None
51
Include endpoints None
51
Remove individuals based on genotype QC
42
P16_FET_NEWB_COMPLICATIO_PLACEN_CORD_MEMBRANES
Control definitions
Control exclude
P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P0[0-4]
Name in latin
Fetus et neonatus complicationibus placentae, funiculi umbilicalis et membranarum fetalium affectus
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Fetus and newborn affected by complications of placenta, cord and membranes
based on the number of shared cases.
Broader endpoints:
- Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 42 | 21 | 21 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 7.53 | 6.34 | 8.72 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: P16_FET_NEWB_COMPLICATIO_PLACEN_CORD_MEMBRANES – Fetus and newborn affected by complications of placenta, cord and membranes
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Fetus and newborn affected by complications of placenta, cord and membranes
↥Endpoint not on priority list, no data to show.